Browsing by Author Simoncini, Edda

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)Citation
2003Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node statusCoates, Alan; Byrne, Michael J.; Castiglione-Gertsch, Monica; Collins, John; Cortes-Funes, Hernan; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Golouh, Rastko; Grigolato, Piergioranni; Lindtner, Jurii; Litman, H; Maffini, Fausto; Martinez-Tello, Francisco J.; Masullo, Michele; Price, Karen; Simoncini, Edda; Spataro, Vito J.; Viale, Giuseppe; School of Public Health: Public HealthDecreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status, Cancer, vol.97,(7),2003,pp 1591-1600
2011Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX.Coates, Alan; Aebi, S; Braun, D; Castiglione-Gertsch, M; Crivellari, Diana; Gelber, Richard; Goldhirsch, A; Gusterson, B. A.; Karlsson, P; Lindtner, Jurii; Price, K. N.; Rabaglio, Manuela; Regan, Meredith M.; Simoncini, Edda; Snyder, Raymond; Sun, Z; Viale, Giuseppe; School of Public Health: Public HealthDifferential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX., Annals of Oncology, vol.22, 9, 2011,pp 1981-1987
2007Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93Coates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; Gelber, Richard D. (Prof); Gelber, Shari; Goldhirsch, Aron (Prof); International, B e; Pagani, O.; Price, Karen N.; Simoncini, Edda; School of Public Health: Public HealthEffects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93, Annals of Oncology 2005, vol.18,(7),2007,pp 1177-1184
2008Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancerCoates, Alan; Castiglione-Gertsch, Monica; Cole, B F; Collins, John; Crivellari, Diana; Fey, Martin F.; Gelber, Richard D. (Prof); Goldhirsch, A; Golouh, Rastko; Gruber, G; Gusterson, Barry; Holmberg, Stig B.; Lindtner, Jurii; Price, K. N.; Simoncini, Edda; Thurlimann, Beat; School of Public Health: Public HealthExtracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer, Annals of Oncology, vol.19, N/A, 2008,pp 1393-1401
2006Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).Coates, Alan; Castiglione-Gertsch, Monica; Collins, John; Crivellari, Diana; Fey, Martin F.; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Holmberg, Stig B.; Lindtner, Jurii; Murray, E.; Pagani, O.; Pestalozzi, B. C.; Price, K. N.; Simoncini, Edda; Zahrieh, David; School of Public Health: Public HealthIdentifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)., Annals of Oncology 2005, vol.17,(6),2006,pp 935-944
2009Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.Coates, Alan; Castiglione-Gertsch, Monica; Collins, John; Crivellari, Diana; et al, various; Gelber, Richard D. (Prof); Gelber, Shari; Holmberg, Stig B.; Lindtner, Jurij; Pagani, O.; Price, Karen N.; Simoncini, Edda; Thurlimann, B.; School of Public Health: Public HealthIs adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93., Breast Cancer Research and Treatment, vol.116, 3,pp 491-500
2009Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group.Coates, Alan; Castiglione-Gertsch, Monica; Fantini, Manuela; Gelber, Richard D. (Prof); Gelber, Shari; Gianni, Lorenzo; Goldhirsch, A; Pagani, O.; Panzini, Ilaria; Price, Karen N.; Ravaioli, Alberto; Simoncini, Edda; School of Public Health: Public HealthSecond non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group., European Journal of Cancer, vol.45, 4,pp 561-571
2005Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumorCoates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; Collins, John; Crivellari, Diana; Erzen, Darja; Forbes, John F.; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Holmberg, S.; Li, S.; Lindtner, Jurii; Murray, E.; Pagani, O.; Price, K. N.; Rudenstam, Carl-Magnus; Simoncini, Edda; Thurlimann, Beat; Veronesi, A.; School of Public Health: Public HealthTiming of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor, Annals of Oncology 2005, vol.16,(5),2005,pp 716-725